MHRA-2022-0008-V208
Major variation for application MHRA-2022-0008. Major variation: Shelf Life Extension for Crizotinabex — critical change
Variation Number
MHRA-2022-0008-V208
Type
Major
Application
Change
Status
Pending
Fee
€51,610
Submitted
2023-01-04
Approved
—
Description
Major variation: Shelf Life Extension for Crizotinabex — critical change